The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide therapy finds a home in San Antonio's wellness market FDA approves WAKIX for narcolepsy in pediatric patients FDA Approves Label Expansion for Agent Used in Patient Selection for Pre Taxane Radioligand Therapy The ASCO Post Everything You Need to Know About the FDA Peptide Ban